P. Alexandersen

发表

The long-term predictive value of bone mineral density measurements for fracture risk is independent of the site of measurement and the age at diagnosis: results from the Prospective Epidemiological Risk Factors study

C. Christiansen, L. Tankó, Y. Bagger, 2005, Osteoporosis International.

Long-Term Prevention with Hormone-Replacement Therapy after the Menopause: Which Women should be Targeted?

M. Karsdal, C. Christiansen, P. Alexandersen, 2009, Women's health.

Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitis.

M. Karsdal, C. Christiansen, P. Alexandersen, 2012, Clinical and experimental rheumatology.

Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects

C. Christiansen, P. Alexandersen, I. Byrjalsen, 2000, BJOG : an international journal of obstetrics and gynaecology.

Norethindrone acetate enhances the antiatherogenic effect of 17beta-estradiol: a secondary prevention study of aortic atherosclerosis in ovariectomized cholesterol-fed rabbits.

C. Christiansen, P. Alexandersen, H. Lawaetz, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Impact of combined hormone replacement therapy on serum lipid metabolism: new aspects.

C. Christiansen, P. Alexandersen, J. Haarbo, 1997, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Non‐Isomerized C‐Telopeptide Fragments Are Highly Sensitive Markers for Monitoring Disease Activity and Treatment Efficacy in Paget's Disease of Bone

P. Alexandersen, L. Alvarez, N. Guañabens, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice

M. Karsdal, L. Tankó, P. Alexandersen, 2006, European Journal of Clinical Pharmacology.

The aging male: testosterone deficiency and testosterone replacement. An up-date.

C. Christiansen, P. Alexandersen, Claus Christiansen, 2004, Atherosclerosis.

Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density

Bjarni V. Halldórsson, B. Halldórsson, D. Gudbjartsson, 2009, Nature Genetics.

Effect of microdose transdermal 17&bgr;-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial

C. Christiansen, P. Alexandersen, C. Muysers, 2009, Menopause.

Hormone replacement as the first-line prevention for postmenopausal osteoporosis

M. Karsdal, C. Christiansen, P. Alexandersen, 2007 .

Raloxifene and estrogen reduces progression of advanced atherosclerosis--a study in ovariectomized, cholesterol-fed rabbits.

C. Christiansen, P. Alexandersen, J. Haarbo, 2001, Atherosclerosis.

Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy.

C. Christiansen, P. Delmas, P. Alexandersen, 2001, The Journal of clinical endocrinology and metabolism.

Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits.

C. Christiansen, P. Alexandersen, H. Lawaetz, 1999, Circulation research.

Bone Densitometry: A New, Highly Responsive Region of Interest in the Distal Forearm to Monitor the Effect of Osteoporosis Treatment

P. Alexandersen, P. Ravn, A. Møllgaard, 1999, Osteoporosis International.

Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study.

C. Christiansen, P. Alexandersen, B. Riis, 1999, The Journal of clinical endocrinology and metabolism.

Safety and Efficacy of a Novel Salmon Calcitonin (sCT) Technology‐Based Oral Formulation in Healthy Postmenopausal Women: Acute and 3‐Month Effects on Biomarkers of Bone Turnover

C. Christiansen, J. Reginster, L. Tankó, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

CAN WE REVERT TO OUR OLD HABITS OF HORMONE THERAPY PRESCRIPTION ?

P. Alexandersen, 2007 .

The long-term impact of 2 – 3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women

C. Christiansen, L. Tankó, Y. Bagger, 2006, Climacteric : the journal of the International Menopause Society.

Algorithm for prescription of HRT or ERT for postmenopausal women

L. Tankó, P. Alexandersen, 2006, Climacteric : the journal of the International Menopause Society.

Central and peripheral fat mass have contrasting effect on the progression of aortic calcification in postmenopausal women.

P. J. Larsen, C. Christiansen, L. Tankó, 2003, European heart journal.

Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent.

C. Christiansen, P. Alexandersen, N. Bjarnason, 2002, Bone.

Breast density changes associated with postmenopausal hormone therapy: post hoc radiologist- and computer-based analyses

M. Nielsen, G. Karemore, M. Loog, 2010, Menopause.

Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women.

J. Holst, C. Christiansen, P. Alexandersen, 2007, Bone.

Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis.

M. Karsdal, C. Christiansen, P. Alexandersen, 2013, Bone.

The effect of menopause and hormone replacement therapy on bone alkaline phosphatase.

P. Alexandersen, C. Hassager, B. Riis, 1995, Scandinavian journal of clinical and laboratory investigation.

Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women.

M. Karsdal, C. Christiansen, J. Reginster, 2007, Bone.

Mechanism of circadian variation in bone resorption.

C. Christiansen, P. Alexandersen, N. Bjarnason, 2002, Bone.

Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women

C. Christiansen, L. Tankó, Y. Bagger, 2005, Osteoporosis International.

Novel Associations Between Bioavailable Estradiol and Adipokines in Elderly Women With Different Phenotypes of Obesity: Implications for Atherogenesis

P. J. Larsen, C. Christiansen, L. Tankó, 2004, Circulation.

The relationship of natural androgens to coronary heart disease in males: a review.

C. Christiansen, P. Alexandersen, J. Haarbo, 1996, Atherosclerosis.

Circadian variation in bone resorption is not related to serum cortisol.

C. Christiansen, P. Alexandersen, C. Hassager, 1997, Bone.

Evaluation of a new commercial IRMA for bone-specific alkaline phosphatase during treatment with hormone replacement therapy and calcitonin.

C. Christiansen, P. Alexandersen, B. Riis, 1996, Clinical chemistry.

The influence of smoking on uterine bleeding during continuous and interrupted oral hormone therapy

C. Christiansen, P. Alexandersen, H. L. Jørgensen, 2007, Climacteric : the journal of the International Menopause Society.

Smoking reduces breast tenderness during oral estrogen–progestogen therapy

C. Christiansen, P. Alexandersen, N. Bjarnason, 2004, Climacteric : the journal of the International Menopause Society.

Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2.

J. Holst, C. Christiansen, P. Alexandersen, 2004, Bone.

Electroacupuncture Therapy for Muscle Atrophy in CKD: Is There a Needle in the Haystack?

C. Christiansen, P. Sulem, G. Thorleifsson, 2015 .

Lack of difference among progestins on the anti-atherogenic effect of ethinyl estradiol: a rabbit study.

C. Christiansen, P. Alexandersen, P. Zandberg, 2003, Human Reproduction.

Circadian Variation in Serum CrossLaps Concentration Is Reduced in Fasting Individuals

P. Alexandersen, P. Ravn, C. Fledelius, 2000 .

New sequence variants associated with bone mineral density

Bjarni V. Halldórsson, B. Halldórsson, D. Gudbjartsson, 2009, Nature Genetics.

Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium

P. Alexandersen, I. Byrjalsen, Glaus Christiansen, 2000, BJOG : an international journal of obstetrics and gynaecology.

Influence of female and male sex steroids on body composition in the rabbit model

C. Christiansen, P. Alexandersen, C. Hassager, 2001, Climacteric : the journal of the International Menopause Society.

Peripheral Adiposity Exhibits an Independent Dominant Antiatherogenic Effect in Elderly Women

Claus Christiansen, László B. Tankó, P. J. Larsen, 2003, Circulation.

Strontium ranelate effect in postmenopausal women with different clinical levels of osteoarthritis

M. Karsdal, C. Christiansen, P. Alexandersen, 2011, Climacteric : the journal of the International Menopause Society.

Comparison of quantitative ultrasound of the phalanges with conventional bone densitometry in healthy postmenopausal women

C. Christiansen, L. Tankó, Y. Bagger, 2005, Osteoporosis International.

Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se?

T. Werge, C. Christiansen, L. Tankó, 2006, Osteoporosis International.

Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.

C. Christiansen, A. Harris, P. Alexandersen, 2016, JAMA.

Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal.

C. Christiansen, L. Tankó, Y. Bagger, 2003, Bone.

Role of hormones in cartilage and joint metabolism: understanding an unhealthy metabolic phenotype in osteoarthritis

M. Karsdal, C. Christiansen, P. Alexandersen, 2012, Menopause.

Genome-wide association study identifies sequence variants on 6q21 associated with age at menarche

D. Gudbjartsson, Á. Jónasdóttir, L. Kiemeney, 2009, Nature Genetics.

Should subchondral bone turnover be targeted when treating osteoarthritis?

K Henriksen, M. Karsdal, C. Christiansen, 2008, Osteoarthritis and cartilage.

Cohort Profile: The Prospective Epidemiological Risk Factor (PERF) study.

M. Karsdal, C. Christiansen, P. Alexandersen, 2016, International journal of epidemiology.

Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis.

M. Karsdal, C. Christiansen, L. Tankó, 2005, Bone.

Matrix Metalloproteinase Mediated Type I Collagen Degradation — An Independent Risk Factor for Mortality in Women

M. Karsdal, C. Christiansen, P. Alexandersen, 2015, EBioMedicine.

Dietary phytoestrogens and estrogen inhibit experimental atherosclerosis

C. Christiansen, P. Alexandersen, V. Breinholt, 2001, Climacteric : the journal of the International Menopause Society.

A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.

M. Karsdal, C. Christiansen, P. Alexandersen, 2016, Bone.

Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD—VIVIAD

P. Scheltens, P. Alexandersen, N. Prins, 2021, Alzheimer's Research & Therapy.

Changes in bone density and turnover after alendronate or estrogen withdrawal

C. Christiansen, Y. Bagger, P. Alexandersen, 2004, Menopause.

Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides.

C. Christiansen, P. Alexandersen, P. Qvist, 1998, Clinical chemistry.

Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials.

M. Karsdal, C. Christiansen, P. Alexandersen, 2015, Osteoarthritis and cartilage.

Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.

C. Christiansen, J. Reginster, P. Alexandersen, 2001, JAMA.

Early postmenopausal hormone therapy may prevent cognitive impairment later in life

C. Christiansen, L. Tankó, Y. Bagger, 2005, Menopause.

Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.

C. Christiansen, J. Kanis, L. Tankó, 2004, Bone.

OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA.

M. Karsdal, C. Christiansen, P. Alexandersen, 2015, Osteoarthritis and cartilage.

Enlarged Waist Combined With Elevated Triglycerides Is a Strong Predictor of Accelerated Atherogenesis and Related Cardiovascular Mortality in Postmenopausal Women

Claus Christiansen, László B. Tankó, P. J. Larsen, 2005, Circulation.

Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD.

J. Holst, C. Christiansen, P. Alexandersen, 2009, Bone.

Role of Gastrointestinal Hormones in Postprandial Reduction of Bone Resorption

J. Holst, C. Christiansen, P. Alexandersen, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Radiographic measure of aorta calcification is a site‐specific predictor of bone loss and fracture risk at the hip

C. Christiansen, L. Tankó, Y. Bagger, 2006, Journal of internal medicine.

The implications of body fat mass and fat distribution for cognitive function in elderly women.

C. Christiansen, L. Tankó, Y. Bagger, 2004, Obesity research.

Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy.

P. Alexandersen, P. Qvist, N. Bjarnason, 2000, Bone.

Ipriflavone in the Treatment of Postmenopausal Osteoporosis

C. Christiansen, J. Reginster, P. Alexandersen, 2017 .

Effects of Nine Hemoglobin Variants on Five Glycohe

P. Alexandersen, P. Qvist, P. Garnero, 2000 .

Associations between Aortic Calcification and Components of Body Composition in Elderly Men

C. Christiansen, L. Tankó, Y. Bagger, 2006, Obesity.